Invitrogen Corp. has acquired product lines and technology rights from Genicon Sciences Corp., including Genicon’s proprietary tools and methods for ultra-sensitive signal generation and detection, for approximately $2 million. Genicon Sciences is a privately held company located in San Diego. “Invitrogen’s goal is to become the preeminent partner for organizations performing disease research and drug Read more about Invitrogen Agrees Deal With Genicon[…]